BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33234055)

  • 1. The Prognostic Value of Circulating VEGF-A Level in Patients With Hepatocellular Cancer.
    Lacin S; Yalcin S
    Technol Cancer Res Treat; 2020; 19():1533033820971677. PubMed ID: 33234055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implication of serum vascular endothelial growth factor in advanced hepatocellular carcinoma staging.
    Yegin EG; Siykhymbayev A; Eren F; Bekiroglu N; Ozdogan OC
    Ann Hepatol; 2013; 12(6):915-25. PubMed ID: 24114822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern.
    Gao F; Zhu HK; Zhu YB; Shan QN; Ling Q; Wei XY; Xie HY; Zhou L; Xu X; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):371-7. PubMed ID: 27498576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma.
    Sharma BK; Srinivasan R; Kapil S; Singla B; Saini N; Chawla YK; Chakraborti A; Duseja A; Kalra N; Dhiman RK
    Mol Cell Biochem; 2013 Nov; 383(1-2):103-12. PubMed ID: 23912396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
    Mukozu T; Nagai H; Matsui D; Kanekawa T; Sumino Y
    Anticancer Res; 2013 Mar; 33(3):1013-21. PubMed ID: 23482775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Kaseb AO; Morris JS; Hassan MM; Siddiqui AM; Lin E; Xiao L; Abdalla EK; Vauthey JN; Aloia TA; Krishnan S; Abbruzzese JL
    J Clin Oncol; 2011 Oct; 29(29):3892-9. PubMed ID: 21911725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation.
    Zhang W; Kim R; Quintini C; Hashimoto K; Fujiki M; Diago T; Eghtesad B; Miller C; Fung J; Tan A; Menon KV; Aucejo F
    Liver Transpl; 2015 Jan; 21(1):101-11. PubMed ID: 25283528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study.
    Poon RT; Ng IO; Lau C; Zhu LX; Yu WC; Lo CM; Fan ST; Wong J
    Ann Surg; 2001 Feb; 233(2):227-35. PubMed ID: 11176129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
    Helaly GF; Abou Shamaa LA
    Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
    Hsieh MY; Lin ZY; Chuang WL
    Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma.
    Poon RT; Ho JW; Tong CS; Lau C; Ng IO; Fan ST
    Br J Surg; 2004 Oct; 91(10):1354-60. PubMed ID: 15376182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
    Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
    Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery.
    Chao Y; Li CP; Chau GY; Chen CP; King KL; Lui WY; Yen SH; Chang FY; Chan WK; Lee SD
    Ann Surg Oncol; 2003 May; 10(4):355-62. PubMed ID: 12734082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of VEGF and HIF-1 α in Hepatocellular Carcinoma Patients Receiving Sorafenib Versus Metformin Sorafenib Combination.
    El Shorbagy S; abuTaleb F; Labib HA; Ebian H; Harb OA; Mohammed MS; Rashied HA; Elbana KA; Haggag R
    J Gastrointest Cancer; 2021 Mar; 52(1):269-279. PubMed ID: 32212089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
    Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
    World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
    Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
    BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
    Zhao J; Hu J; Cai J
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):389-92. PubMed ID: 11810769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.
    Kaseb AO; Hassan MM; Lin E; Xiao L; Kumar V; Pathak P; Lozano R; Rashid A; Abbruzzese JL; Morris JS
    Cancer; 2011 Jun; 117(11):2478-88. PubMed ID: 24048796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
    Pang Q; Bi JB; Xu XS; Liu SS; Zhang JY; Zhou YY; Qu K; Liu C
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1337-46. PubMed ID: 26275082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.